NCT05170113View on ClinicalTrials.gov

Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 2, 2021

Primary Completion Date

May 31, 2022

Study Completion Date

May 31, 2022

Conditions

Fatigue

Interventions

DIETARY_SUPPLEMENT

Alpinia galanga formulation

Alpinia galanga formulation capsule- 1 capsule daily

DIETARY_SUPPLEMENT

Theacrine formulation

Theacrine formulation capsule- 1 capsule daily

DIETARY_SUPPLEMENT

Caffeine formulation

Caffeine formulation capsule- I capsule daily

DIETARY_SUPPLEMENT

Placebo

Placebo capsule- 1 capsule daily

Trial Locations (1)

33304

Life Extension Clinical Research, Fort Lauderdale

All Listed Sponsors

lead

Supplement Formulators, Inc.

INDUSTRY

NCT05170113 - Evaluate the Effectiveness and Safety of the Alpinia Galanga Formulation, Theacrine Formulation, and Caffeine Formulation on Fatigue, Mental Acuity, and Cognitive Health | Biotech Hunter | Biotech Hunter